Colonoscopy Still Outperforms Blood Tests | AI Enhances Pancreatic Lesion Detection | Wireless Patch Offers Noninvasive GI Motility Testing
Praveen Suthrum
Cofounder, NextServices | Author, The Shift, Scope Forward | GI Mastermind
Buy?The Shift?on your local Amazon here:?https://geni.us/TheShiftBySuthrum . The Kindle eBook continues to be available for?99￠!
The FDA-approved blood test offers a less invasive option for colorectal cancer screening, though it’s less effective than colonoscopies in detection and prevention.
New on Scope Forward: What if the Future is Already Here? – Praveen, Author of "The Shift" (The Scope Forward Show)
Join a fascinating interview where Maya, an AI avatar, interviews Praveen Suthrum, author of The Shift, to unpack the future of gastroenterology and healthcare.
At the ACG 2024, researchers presented an AI tool that identifies and differentiates pancreatic cystic and solid lesions with remarkable accuracy during endoscopic ultrasound (EUS).
Guardant Health Named to TIME’s List of the Best Inventions of 2024 (Guardant Health)
Guardant Health’s Shield? has been included in TIME magazine's 2024 list of the Best Inventions, which recognizes 200 innovations impacting healthcare, AI, and other fields.
A recent study by WovenX Health showcased the potential of on-demand telehealth in cutting emergency department visits and associated healthcare costs for GI symptoms.
The Healio Disruptive Innovator Awards, held at the American College of Gastroenterology's Annual Meeting, spotlighted leading-edge advancements across gastroenterology and hepatology.
Multisociety Clinical Practice Guidance for the Safe Use of Glucagon-like Peptide-1 Receptor Agonists in the Perioperative Period (Clinical GI & Hepatology)
The recent multisociety clinical practice document provides guidance on the perioperative management of GLP-1 receptor agonists (GLP-1RAs), emphasizing shared decision-making and tailored patient care.
领英推荐
Legislation would block Medicare cut, increase 2025 physician reimbursement (Medical Economics)
Lawmakers and physician groups, including the AMA and MGMA, back the Medicare Patient Access and Practice Stabilization Act to prevent a 2.8% Medicare cut and add a 1.8% increase for 2025.
Brian Lacy, MD, PhD: Rethinking Motility Testing with a Noninvasive Wireless Patch System (HCP Live)
A new study presented at the ACG 2024 meeting suggests that a wireless motility patch system could offer a more comprehensive, noninvasive way to monitor multiday GI activity.
Richard Close, Managing Director, Digital and Tech-Enabled Health Equity Research at Canaccord Genuity, talks about potential election outcomes and how they could impact healthcare investing.
This FDA-approved, single-use ingestible capsule uses light-absorption technology to detect bleeding in the upper GI tract with 93% sensitivity and 91% specificity.
This distinction places Dr. Gagneja among only 172 of over 18,000 ACG members who have achieved this honor.
Eli Lilly and Johnson & Johnson are seeking label expansions for Omvoh and Tremfya, respectively, in Crohn’s disease following approvals for ulcerative colitis.
OpenBiome, a nonprofit supplying fecal microbiota transplantation (FMT) material, announced a voluntary suspension of its distribution this week, affecting many clinical sites across the U.S.
For weekly gastroenterology business/tech updates directly in your inbox, subscribe to the Scope Forward newsletter .